Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AB-110
Trade Name
Synonyms CD34-positive Enriched HPCs Mixed with Engineered Human ECs AB-110
Drug Descriptions

AB-110 is a preparation of umbilical cord blood-derived CD34-positive hematopoietic progenitor cells mixed with endothelial cells engineered to express the adenovirus E4ORF1 gene, potentially resulting in increased engraftment upon transplantation (NCI Drug Dictionary).

CAS Registry Number NA
NCIT ID C150135


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AB-110 AB-110 0 1

Additional content available in CKB BOOST